CN1385204A - Antianaphylactic Chinese medicine preparation - Google Patents
Antianaphylactic Chinese medicine preparation Download PDFInfo
- Publication number
- CN1385204A CN1385204A CN 02115922 CN02115922A CN1385204A CN 1385204 A CN1385204 A CN 1385204A CN 02115922 CN02115922 CN 02115922 CN 02115922 A CN02115922 A CN 02115922A CN 1385204 A CN1385204 A CN 1385204A
- Authority
- CN
- China
- Prior art keywords
- radix angelicae
- chinese medicine
- radix
- medicine preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine preparation for removing and curing penicillin anaphylaxis with obvious therapeutic effect is made of 13 Chinese medicinal materials of frankincense, myrrh, fennel fruit, aquilaria wood, Chinese angelica root, cinnamon bark and others. Said preparation has no toxic side effect.
Description
[technical field]
The invention belongs to medical preparation, relate to a kind of antiallergic Chinese medicine preparation.
[background technology]
The difference of human body constitution and the shortage of some material, causing some people easily to produce anaphylaxis is allergic constitution, it comprises: physiological allergy, medicine allergy etc., as pollen, penicillin etc.In to the treatment of allergic constitution, adopt its curative effect of Chinese medicine method also fine.Also have in the prior art, as application number is 98115850, " giant gold silkwork Chinese medicine detoxicating preparation " by name, mainly by Radix Et Rhizoma Rhei, Flos Lonicerae, Bombyx Batryticatus, Periostracum Cicadae, Herba Menthae, Radix Bupleuri, Rhizoma Curcumae Longae are formed, to in the urticaria treatment antianaphylactic significantly curative effect being arranged, but with regard in the prior art at various drug allergy, particularly in the therapeutic process at penicillin anaphylaxis, mostly adopt " skin test " epidemic prevention, after the allergy, adopt oxygen uptake immediately, epinephrine, dexamethasone, massage, emergency measures such as promethazine or diphenhydramine.Still find no scheme based on the treatment and the epidemic prevention of Chinese medicine.
[summary of the invention]
Purpose of the present invention is exactly that will provide with Chinese medicine is a kind of antiallergic Chinese medicine preparation that is mainly used to penicillin anaphylaxis.
The present invention is achieved in that mainly and is made up of Olibanum, Myrrha, Fructus Foeniculi, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, pollen, Fructus Chaenomelis, the Radix Angelicae Dahuricae, Resina Draconis, Flos Carthami that the percentage by weight between its each composition is:
Olibanum 6～11%
Myrrha 6～11%
Fructus Foeniculi 3～7%
Lignum Aquilariae Resinatum 3～7%
Radix Angelicae Sinensis 6～11%
Cortex Cinnamomi 3～7%
Rhizoma Et Radix Notopterygii 6～11%
Radix Angelicae Pubescentis 6～11%
Pollen 6～11%
Fructus Chaenomelis 6～11%
The Radix Angelicae Dahuricae 3～7%
Resina Draconis 6～11%
Flos Carthami 6～11%
After each composition and the ratio, preparation can occur in a variety of forms as capsule, granule, electuary more than selecting, oral liquid, tablets etc. are when making these kinds, some necessary appurtenances can be added,, but percentage ratio between each composition of the present invention can not be influenced as water, starch, sugar etc.
The present invention adopts the natural Chinese medicines composition to form, and is anti-evident in efficacy to penicillin medicine releasing hypersensitive and epidemic disease, has no side effect, and with respect to prior art outstanding progress arranged.Filled up the blank of Chinese herb prevention penicillin anaphylaxis.The present invention is also effective in cure to gentamycin anaphylaxis.
[specific embodiment]
The present invention is further provided by following examples:
Embodiment 1: the percentage by weight between selected each composition is:
Olibanum 7.77%
Myrrha 7.77%
Fructus Foeniculi 5.00%
Lignum Aquilariae Resinatum 5.54%
Radix Angelicae Sinensis 9.77%
Cortex Cinnamomi 5.53%
Rhizoma Et Radix Notopterygii 8.77%
Radix Angelicae Pubescentis 9.77%
Pollen 9.77%
Fructus Chaenomelis 7.77%
The Radix Angelicae Dahuricae 5.00%
Resina Draconis 7.77%
Flos Carthami 9.77%
Embodiment 2: the percentage by weight between selected each composition is:
Olibanum 8.77%
Myrrha 8.77%
Fructus Foeniculi 5.27%
Lignum Aquilariae Resinatum 5.27%
Radix Angelicae Sinensis 8.77%
Cortex Cinnamomi 5.27%
Rhizoma Et Radix Notopterygii 8.77%
Radix Angelicae Pubescentis 8.77%
Pollen 8.77%
Fructus Chaenomelis 8.77%
The Radix Angelicae Dahuricae 5.26%
Resina Draconis 8.77%
Flos Carthami 8.77%
Embodiment 3: the percentage by weight between each composition of selected back is:
Olibanum 9.77%
Myrrha 9.77%
Fructus Foeniculi 5.54%
Lignum Aquilariae Resinatum 5.00%
Radix Angelicae Sinensis 7.77%
Cortex Cinnamomi 5.00%
Rhizoma Et Radix Notopterygii 9.77%
Radix Angelicae Pubescentis 7.77%
Pollen 7.77%
Fructus Chaenomelis 9.77%
The Radix Angelicae Dahuricae 5.53%
Resina Draconis 8.77%
Flos Carthami 7.77%
More than each embodiment get above each composition in proportion after really, be crushed to about 100 orders, add an amount of water, sugar etc., make granule, electuary, with 2.5 grams is that unit packaging is gone into dress, or adds an amount of starch again and can become tablet, or adopts mode such as directly boil medicine to make oral liquid.Removing its property of medicine composition of appurtenance with per unit and be as the criterion with 2.5 grams, is a unit consumption.
Claims (1)
1, a kind of antiallergic Chinese medicine preparation, it mainly is made up of Olibanum, Myrrha, Fructus Foeniculi, Lignum Aquilariae Resinatum, Radix Angelicae Sinensis, Cortex Cinnamomi, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, pollen, Fructus Chaenomelis, the Radix Angelicae Dahuricae, Resina Draconis, Flos Carthami, and the percentage by weight between its each composition is:
Olibanum 6～11%
Myrrha 6～11%
Fructus Foeniculi 3～7%
Lignum Aquilariae Resinatum 3～7%
Radix Angelicae Sinensis 6～11%
Cortex Cinnamomi 3～7%
Rhizoma Et Radix Notopterygii 6～11%
Radix Angelicae Pubescentis 6～11%
Pollen 6～11%
Fructus Chaenomelis 6～11%
The Radix Angelicae Dahuricae 3～7%
Resina Draconis 6～11%
Flos Carthami 6～11%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02115922 CN1385204A (en) | 2002-05-31 | 2002-05-31 | Antianaphylactic Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02115922 CN1385204A (en) | 2002-05-31 | 2002-05-31 | Antianaphylactic Chinese medicine preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1385204A true CN1385204A (en) | 2002-12-18 |
Family
ID=4743949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02115922 Pending CN1385204A (en) | 2002-05-31 | 2002-05-31 | Antianaphylactic Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1385204A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105833325A (en) * | 2016-04-07 | 2016-08-10 | 永春县达埔彬达制香厂有限公司 | Natural mixed incense having anti-allergy function and preparation method of natural mixed incense |
| CN106192554A (en) * | 2016-07-22 | 2016-12-07 | 阜南县金威工艺品有限公司 | Paper anti-allergic agent is used in a kind of braiding |
-
2002
- 2002-05-31 CN CN 02115922 patent/CN1385204A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105833325A (en) * | 2016-04-07 | 2016-08-10 | 永春县达埔彬达制香厂有限公司 | Natural mixed incense having anti-allergy function and preparation method of natural mixed incense |
| CN106192554A (en) * | 2016-07-22 | 2016-12-07 | 阜南县金威工艺品有限公司 | Paper anti-allergic agent is used in a kind of braiding |
| CN106192554B (en) * | 2016-07-22 | 2018-07-03 | 阜南县金威工艺品有限公司 | A kind of braiding paper anti-allergic agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899505A (en) | Medicine composition for clearing heat and purging-fire | |
| CN1943751A (en) | A health-protective pharmaceutical for activating and improving intellect and its preparation method | |
| CN1772100A (en) | Medicine for treating psoriasis and its prepn | |
| CN1927279A (en) | Chinese medicine composition for treating skin disease | |
| CN1709288A (en) | Medicinal composition, and its preparing method and use | |
| CN1385204A (en) | Antianaphylactic Chinese medicine preparation | |
| CN1049586C (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1203888C (en) | Medicine for treating various fungal skin disease or bromidrosis | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1385203A (en) | Compound Chinese medicine preparation of damnacanthus | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1943732A (en) | A medicinal composition for treatment of psoriasis | |
| CN1686414A (en) | Wound dispelling swell dispersing tincture and its preparation method | |
| CN1186028C (en) | Antagesic Chinese medicine and its preparing process and usage | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1212150C (en) | Medicine for treating virus hepatitis and its preparation method | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1356117A (en) | Capsule 'Tangniaoshenkang' for treating diabetes | |
| CN1075725C (en) | Medicaments for treating thrombocytopenic purpura and anaemia | |
| CN1463192A (en) | Herb compsns. for treating dopy and agrypnia | |
| CN1602921A (en) | Medicine for treating diabetes and its preparing process | |
| CN1314169A (en) | Medicine for treating hepatitis B | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1099875C (en) | Dermatosis treating medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |